raw scansnapshot — prices as of scan date, not live46 rows · screens, not recommendationssuperseded by2026-04-26-insider-scanported fromresearch/classic/scans/_archive/2026-03-12-insider-scan.mdscan sluginsider-scansource typescan-archive
Zero golden signals today — smart money is quietly buying TSLA, CRSP, and ASAN while dumping $10B+ of AMZN, LLY, and PLTR; ZM and EOSE are the danger flags with insiders selling directly into oversold dips.
Quick Snapshot
Signal
Reading
Overall
🔴 HEAVY SELLING ENVIRONMENT — 49 of 59 stocks show net insider selling; 2 danger signals (selling into oversold dips); zero golden signals
Buying signals
TSLA (+$191.3M), CRSP (+$28M), ASAN (+$8.3M) — all net positive insider activity
TSLA ($399.93, RSI 43.9, +$191M buying) — Musk-adjacent buying meaningful here. -4.1% 30D, weakening trend, but insider conviction at this level is notable. Not oversold but clear accumulation signal.
CRSP ($48.87, RSI 39.4, +$28M buying) — Gene editing at multi-year lows. -13.9% 7D suggests recent catalyst/disappointment. Insider buying into the panic sell. Thesis: platform value intact despite near-term headwinds.
ASAN ($6.97, RSI 32.7, +$8.3M buying) — Work management SaaS at historic lows. -51.4% 3M, -63.3% from 52wk high. Insider buying into a brutal decline. Speculative but notable.
Tier 2 — Danger Signals (Selling Into Dip)
ZM ($75.29, RSI 35.1, -$209.7M selling) — Zoom is in a deep decline (-18.4% 30D, -8.1% below SMA20) AND insiders are abandoning ship. When RSI approaches 35 but insiders aren't buying, it's a falling knife, not a bargain.
EOSE ($6.19, RSI 30.8, -$21.9M selling) — Energy storage company down -42.6% 30D and -26.9% below SMA20. Insiders selling at the lows = potential thesis failure. Avoid until stabilization.
Tier 3 — Heavy Sellers (Caution on Breakouts)
NFLX (+$24.8% 30D, RSI 61.4, -$1.3B insider selling) — Insiders trimming into a significant bounce. The 7D -3.6% suggests the move may be stalling.
NET (+14.9% 30D, RSI 66.4, -$741.8M selling) — Cloudflare ripping +10.9% 7D but insiders selling aggressively. Approaching overbought.
PLTR (+19.8% 30D, RSI 57.3, -$3.7B selling) — Big recovery but insiders selling hard. Not a long-term hold here.
Tier 4 — Near-Oversold but No Insider Buying
TMO (RSI 27.5, -6.5% 30D) — Life sciences tools at deep oversold without insider buying. Could be first to recover in sector rotation.
MDB (RSI 32.9, -26.5% 30D) — MongoDB in post-earnings wreckage. Insiders not yet buying.
BNTX (RSI 33.3, -16.0% 30D) — BioNTech broken down significantly. No buying signal.